Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hinge Health (HNGE) Asset Writedowns and Impairment (2024)

Hinge Health recorded quarterly Asset Writedowns and Impairment of -$12000.0 in Q4 2024, down 100.92% quarter-over-quarter from $1.3 million in Q2 2024.

Hinge Health's Asset Writedowns and Impairment history runs 1 years deep, the most recent figure standing at -$12000.0 for Q4 2024.

  • In Q4 2024, Asset Writedowns and Impairment changed N/A year-over-year to -$12000.0; the TTM figure through Dec 2025 stood at -$12000.0 (changed N/A YoY), while the FY2024 annual figure was $1.8 million, down 82.46% from the prior year.
  • Asset Writedowns and Impairment came in at -$12000.0 for Q4 2024 at Hinge Health, down from $1.3 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $1.3 million in Q2 2024 to a low of -$12000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 GE HealthCare Technologies 29.29 Bn 27.22 Bn 1.98 Bn
2 Veeva Systems 26.21 Bn 19.65 Bn 622.47 Mn
3 BrightSpring Health Services 11.98 Bn 11.10 Bn 482.22 Mn
4 Healthequity 7.59 Bn 7.27 Bn 228.15 Mn
5 Hinge Health 4.34 Bn 4.03 Bn 154.23 Mn
6 Waystar Holding 3.75 Bn 3.59 Bn 268.04 Mn
7 Doximity 3.73 Bn 2.98 Bn 125.97 Mn
8 10x Genomics 3.04 Bn 2.50 Bn 106.18 Mn
9 Privia Health 2.83 Bn 2.46 Bn 595.71 Mn
10 Omnicell 2.01 Bn 1.84 Bn 140.36 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 -12,000.00
Dec 31, 2024 -12,000.00
Jun 30, 2024 1.30 Mn
Jun 30, 2024 1.30 Mn